First US Patient Enrolled in i-Lumen’s Bioelectric Dry AMD Trial
Clinical Trials for Noninvasive Dry AMD Therapy Expand to the US The i-SIGHT2 pivotal clinical trial has officially begun in the United States, with the first patient randomized at Texas Retina Associates in Fort Worth. This study evaluates the i-Lumen AMD System, an investigational, office-based device designed to treat intermediate to advanced dry age-related macular … Read more